SCHEMBL16824845

SCHEMBL16824845

O=Cc1cc([N+](=O)[O-])ccc1N1CCCCC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.74
GAA P10253 1/20 0.66
SMN1; SMN2 Q16637 5/20 0.59
LMNA P02545 3/20 0.58
CYP1A2 P05177 3/20 0.57
CYP3A4 P08684 3/20 0.57
CYP2C9 P11712 3/20 0.57
CYP2C19 P33261 3/20 0.57
NPSR1 Q6W5P4 1/20 0.57
HPGD P15428 1/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
MAPT P10636 4/20 0.55
ALDH1A3 P47895 1/20 0.55
CYP2D6 P10635 1/20 0.54
MCOLN3 Q8TDD5 1/20 0.54
ERN1 O75460 1/20 0.51
POLB P06746 1/20 0.51
HTT P42858 1/20 0.51
PAX8 Q06710 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6257607 1.00 ALDH1A1 (0.74) ALDH1A1GAASMN1; SMN2LMNACYP1A2
SCHEMBL28032257 0.98 ALDH1A1 (0.76) ALDH1A1GAASMN1; SMN2LMNACYP1A2
SCHEMBL1969786 0.85 ALDH1A1 (0.71) ALDH1A1GAASMN1; SMN2LMNACYP1A2
SCHEMBL16569921 0.85 ALDH1A1 (0.71) ALDH1A1GAALMNACYP1A2CYP3A4
SCHEMBL1475607 0.85 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2LMNACYP1A2CYP3A4
SCHEMBL16824985 0.84 ALDH1A1 (0.69) ALDH1A1GAASMN1; SMN2LMNAKMT2A
SCHEMBL16824981 0.83 ALDH1A1 (0.67) ALDH1A1GAASMN1; SMN2LMNAKMT2A
SCHEMBL16824983 0.83 ALDH1A1 (0.67) ALDH1A1GAASMN1; SMN2LMNAHPGD
SCHEMBL16824862 0.82 ALDH1A1 (0.66) ALDH1A1GAASMN1; SMN2LMNAHPGD
SCHEMBL16824854 0.82 MAPT (0.67) ALDH1A1GAASMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106415244-B Reactive marker compounds and uses thereof 中央研究院 2020-04-24 CN disclosed
CN-105829315-B Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors 阿尔麦克探索有限公司 2019-03-08 CN disclosed
US-10119972-B2 Reactive labelling compounds and uses thereof ACADEMIA SINICA (TW) 2018-11-06 US disclosed
US-20180011104-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF ACADEMIA SINICA (TW) 2018-01-11 US disclosed
US-9850247-B2 Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors ALMAC HOUSE (GB) 2017-12-26 US disclosed
EP-3083625-B1 PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS ALMAC DISCOVERY LTD (GB) 2017-11-01 EP disclosed
US-9759726-B2 Reactive labelling compounds and uses thereof ACADEMIA SINICA (TW) 2017-09-12 US disclosed
EP-3129767-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF Academia Sinica (TW) 2017-02-15 EP disclosed
CN-106415244-A Reactive marker compounds and uses thereof 中央研究院 2017-02-15 CN disclosed
WO-2015148915-A9 REACTIVE LABELLING COMPOUNDS AND USES THEREOF ACADEMIA SINICA (TW) 2016-12-22 WO disclosed
US-20160318936-A1 PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS ALMAC DISCOVERY LIMITED (GB) 2016-11-03 US disclosed
EP-3083625-A1 PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS Almac Discovery Limited (GB) 2016-10-26 EP disclosed
CN-105829315-A Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors 阿尔麦克探索有限公司 2016-08-03 CN disclosed
US-20150309041-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF ACADEMIA SINICA (TW) 2015-10-29 US disclosed
WO-2015148915-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF ACADEMIA SINICA (TW) 2015-10-01 WO disclosed
WO-2015092431-A1 PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS ALMAC DISCOVERY LIMITED (GB) 2015-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150309041-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF MPI, AADAC, PAICS ALDH1A1 364/4885GAA 20/4885SMN1; SMN2 4607/4885
US-20180011104-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF MPI, AADAC, PAICS ALDH1A1 273/4885GAA 27/4885SMN1; SMN2 4626/4885
US-20160318936-A1 PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS WEE1, WEE2, NME1 ALDH1A1 1940/4885GAA 1730/4885SMN1; SMN2 4422/4885
US-10119972-B2 Reactive labelling compounds and uses thereof MPI, AADAC, PAICS ALDH1A1 273/4885GAA 27/4885SMN1; SMN2 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.